CT texture analysis can be a potential tool to differentiate gastrointestinal stromal tumors without KIT exon 11 mutation

被引:36
作者
Xu, Fei [1 ,2 ]
Ma, Xiaohong [1 ,2 ]
Wang, Yichen [1 ,2 ]
Tian, Yuan [1 ,2 ]
Tang, Wei [1 ,2 ]
Wang, Meng [2 ,3 ]
Wei, Ren [4 ]
Zhao, Xinming [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Dept Imaging Diag, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[2] Peking Union Med Coll, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[3] Chinese Acad Med Sci, Dept Epidemiol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, 17 Panjiayuan Nanli, Beijing 100021, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, 6 Tiantan Xili, Beijing 100050, Peoples R China
关键词
Gastrointestinal stromal tumor; CT; Texture analysis; KIT mutation; PDGFRA MUTATIONS; CELL CARCINOMA; SARCOMA-GROUP; LUNG-CANCER; IMATINIB; PREDICTION; SURVIVAL; THERAPY; TRIAL; LEIOMYOSARCOMAS;
D O I
10.1016/j.ejrad.2018.07.025
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To evaluate CT texture analysis as a tool to differentiate gastrointestinal stromal tumors (GISTs) without KIT exon 11 mutation. Materials and methods: This study consisted of a study group of 69 GISTs and a validation group of 17 GISTs. Clinical information of the patients were collected and analyzed. Two-dimensional and three-dimensional texture analysis was performed. The textural parameters were evaluated in the study group and were validated in the validation group. The repeatability of the textural parameters on the single region of interest (single-ROI), double-ROI, and whole volume of interest (whole-VOI) was analyzed. The independent predictor for the GIST genotypes was analyzed with logistic regression models. The support vector machine (SVM) classifiers were also trained and 6-fold cross validation ROC curves were computed. Subjective heterogeneity scores of each lesion on enhanced CT images were given by radiologists and the corresponding difference of the heterogeneity rating was evaluated. Results: The non-gastric location, lower CD34_stain level and higher textural parameter standard Deviation (stdDeviation) were associated with the GISTs without KIT exon 11 mutation in the study group. The cross validation SVM classifiers achieved with combination of stdDeviation, anatomic location and CD34_stain level demonstrated medium to good prediction efficiency (AUC = 0.864-0.904) regarding the GIST genotypes. The stdDeviation was an independent predictor of GISTs without KIT exon 11 mutation, and had a medium correlation with the GIST genotypes in the study group (AUC = 0.726-0.750). The stdDeviation showed good performance (AUC = 0.904-0.962) when validated in the validation group. The double-ROIs improved the performances of single-ROIs, decreasing the variances of single-ROIs brought by section-selection, and demonstrating excellent agreements between ROIs and whole-VOI. Subjective heterogeneity scores had no statistically significant differences between GIST genotypes. Conclusion: CT texture analysis can potentially help to differentiate GISTs without KIT exon 11 mutation from those GISTs with KIT exon 11 mutation on enhanced CT images.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 24 条
[1]   Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach [J].
Aerts, Hugo J. W. L. ;
Velazquez, Emmanuel Rios ;
Leijenaar, Ralph T. H. ;
Parmar, Chintan ;
Grossmann, Patrick ;
Cavalho, Sara ;
Bussink, Johan ;
Monshouwer, Rene ;
Haibe-Kains, Benjamin ;
Rietveld, Derek ;
Hoebers, Frank ;
Rietbergen, Michelle M. ;
Leemans, C. Rene ;
Dekker, Andre ;
Quackenbush, John ;
Gillies, Robert J. ;
Lambin, Philippe .
NATURE COMMUNICATIONS, 2014, 5
[2]   Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis [J].
Ahn, Su Joa ;
Kim, Jung Hoon ;
Park, Sang Joon ;
Han, Joon Koo .
EUROPEAN JOURNAL OF RADIOLOGY, 2016, 85 (10) :1867-1874
[3]   Quantitative CT texture and shape analysis: Can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? [J].
Bayanati, Hamid ;
Thornhill, Rebecca E. ;
Souza, Carolina A. ;
Sethi-Virmani, Vineeta ;
Gupta, Ashish ;
Maziak, Donna ;
Amjadi, Kayvan ;
Dennie, Carole .
EUROPEAN RADIOLOGY, 2015, 25 (02) :480-487
[4]   Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial [J].
Corless, Christopher L. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Kolesnikova, Violetta ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
Demetri, George D. ;
Heinrich, Michael C. ;
von Mehren, Margaret ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Owzar, Kouros ;
DeMatteo, Ronald P. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15) :1563-U61
[5]   PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib [J].
Corless, CL ;
Schroeder, A ;
Griffith, D ;
Town, A ;
McGreevey, L ;
Harrell, P ;
Shiraga, S ;
Bainbridge, T ;
Morich, J ;
Heinrich, MC .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) :5357-5364
[6]   Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group [J].
Debiec-Rychter, M ;
Dumez, H ;
Judson, I ;
Wasag, B ;
Verweij, J ;
Brown, M ;
Dimitrijevic, S ;
Sciot, R ;
Stul, M ;
Vranck, H ;
Scurr, M ;
Hagemeijer, A ;
Van Glabbeke, M ;
van Oosterom, AT .
EUROPEAN JOURNAL OF CANCER, 2004, 40 (05) :689-695
[7]   Contrast of response to dacarbazine, mitomycin, doxorubicin, and cisplatin (DMAP) plus GM-CSF between patients with advanced malignant gastrointestinal stromal tumors and patients with other advanced leiomyosarcomas [J].
Edmonson, JH ;
Marks, RS ;
Buckner, JC ;
Mahoney, MR .
CANCER INVESTIGATION, 2002, 20 (5-6) :605-612
[8]   Pre-treatment MDCT-based texture analysis for therapy response prediction in gastric cancer: Comparison with tumour regression grade at final histology [J].
Giganti, Francesco ;
Marra, Paolo ;
Ambrosi, Alessandro ;
Salerno, Annalaura ;
Antunes, Sofia ;
Chiari, Damiano ;
Orsenigo, Elena ;
Esposito, Antonio ;
Mazza, Elena ;
Albarello, Luca ;
Nicoletti, Roberto ;
Staudacher, Carlo ;
Del Maschio, Alessandro ;
De Cobelli, Francesco .
EUROPEAN JOURNAL OF RADIOLOGY, 2017, 90 :129-137
[9]   CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib [J].
Haider, Masoom A. ;
Vosough, Alireza ;
Khalvati, Farzad ;
Kiss, Alexander ;
Ganeshan, Balaji ;
Bjarnason, Georg A. .
CANCER IMAGING, 2017, 17
[10]   Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor [J].
Heinrich, MC ;
Corless, CL ;
Demetri, GD ;
Blanke, CD ;
von Mehren, M ;
Joensuu, H ;
McGreevey, LS ;
Chen, CJ ;
Van den Abbeele, AD ;
Druker, BJ ;
Kiese, B ;
Eisenberg, B ;
Roberts, PJ ;
Singer, S ;
Fletcher, CDM ;
Silberman, S ;
Dimitrijevic, S ;
Fletcher, JA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4342-4349